The Bahrain Oncology Centre announced on Sunday it had successfully treated a sickle cell disease patient using CRISPR-based gene-editing therapy Casgevy.
It is designed as a potential treatment for SCD and transfusion-dependent beta-thalassemia.
The initiative is part of Bahrain's national healthcare strategy, which prioritizes medical innovation and collaboration.
A customized collection of grant news from foundations and the federal government from around the Web.
The Charities Aid Foundation has set up a scheme, called the Social Enterprise Assist, that will render interest-free loans of up to £10,000 each to help social enterprise start-ups.